vs
Side-by-side financial comparison of Stoke Therapeutics, Inc. (STOK) and Triumph Financial, Inc. (TFIN). Click either name above to swap in a different company.
Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $120.1M, roughly 1.3× Triumph Financial, Inc.). On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 16.0%).
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
The Triumph Motor Company was a British car and motor manufacturing company in the 19th and 20th centuries. The marque had its origins in 1885 when Siegfried Bettmann of Nuremberg formed S. Bettmann & Co. and started importing bicycles from Europe and selling them under his own trade name in London. The trade name became "Triumph" the following year, and in 1887 Bettmann was joined by a partner, Moritz Schulte, also from Germany. In 1889, the businessmen started producing their own bicycles i...
STOK vs TFIN — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $158.6M | $120.1M |
| Net Profit | $112.9M | — |
| Gross Margin | — | — |
| Operating Margin | 70.2% | — |
| Net Margin | 71.2% | — |
| Revenue YoY | 3661.1% | 16.0% |
| Net Profit YoY | 528.0% | 400.6% |
| EPS (diluted) | $1.90 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $120.1M | ||
| Q3 25 | — | $109.3M | ||
| Q2 25 | — | $108.1M | ||
| Q1 25 | $158.6M | $101.6M | ||
| Q4 24 | $22.6M | $103.6M | ||
| Q3 24 | — | $106.2M | ||
| Q2 24 | — | $105.1M | ||
| Q1 24 | — | $101.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | $1.7M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | $112.9M | $17.0K | ||
| Q4 24 | $-10.5M | $3.8M | ||
| Q3 24 | — | $5.3M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $4.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 7.3% | ||
| Q1 25 | 70.2% | 0.1% | ||
| Q4 24 | -60.4% | 5.6% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | 4.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 4.1% | ||
| Q1 25 | 71.2% | 0.0% | ||
| Q4 24 | -46.4% | 3.7% | ||
| Q3 24 | — | 5.0% | ||
| Q2 24 | — | 2.6% | ||
| Q1 24 | — | 4.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | $0.04 | ||
| Q2 25 | — | $0.15 | ||
| Q1 25 | $1.90 | $-0.03 | ||
| Q4 24 | $-0.15 | $0.13 | ||
| Q3 24 | — | $0.19 | ||
| Q2 24 | — | $0.08 | ||
| Q1 24 | — | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $274.8M | $248.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $350.1M | $941.8M |
| Total Assets | $406.9M | $6.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $248.5M | ||
| Q3 25 | — | $147.2M | ||
| Q2 25 | — | $282.3M | ||
| Q1 25 | $274.8M | $502.9M | ||
| Q4 24 | $128.0M | $330.1M | ||
| Q3 24 | — | $489.3M | ||
| Q2 24 | — | $500.7M | ||
| Q1 24 | — | $417.0M |
| Q4 25 | — | $941.8M | ||
| Q3 25 | — | $919.3M | ||
| Q2 25 | — | $912.4M | ||
| Q1 25 | $350.1M | $893.9M | ||
| Q4 24 | $229.0M | $890.9M | ||
| Q3 24 | — | $885.8M | ||
| Q2 24 | — | $874.2M | ||
| Q1 24 | — | $872.3M |
| Q4 25 | — | $6.4B | ||
| Q3 25 | — | $6.4B | ||
| Q2 25 | — | $6.5B | ||
| Q1 25 | $406.9M | $6.3B | ||
| Q4 24 | $271.6M | $5.9B | ||
| Q3 24 | — | $5.9B | ||
| Q2 24 | — | $5.8B | ||
| Q1 24 | — | $5.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $131.8M | $67.1M |
| Free Cash FlowOCF − Capex | $131.7M | — |
| FCF MarginFCF / Revenue | 83.0% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | 1.17× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $67.1M | ||
| Q3 25 | — | $24.4M | ||
| Q2 25 | — | $9.8M | ||
| Q1 25 | $131.8M | $-3.6M | ||
| Q4 24 | $-23.2M | $58.5M | ||
| Q3 24 | — | $26.6M | ||
| Q2 24 | — | $21.9M | ||
| Q1 24 | — | $-10.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | $22.4M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | $131.7M | $-7.9M | ||
| Q4 24 | $-23.2M | — | ||
| Q3 24 | — | $25.8M | ||
| Q2 24 | — | $-31.9M | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 20.5% | ||
| Q2 25 | — | 6.2% | ||
| Q1 25 | 83.0% | -7.7% | ||
| Q4 24 | -102.7% | — | ||
| Q3 24 | — | 24.3% | ||
| Q2 24 | — | -30.3% | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.8% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | 0.1% | 4.2% | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 51.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 14.29× | ||
| Q2 25 | — | 2.22× | ||
| Q1 25 | 1.17× | -212.82× | ||
| Q4 24 | — | 15.25× | ||
| Q3 24 | — | 4.97× | ||
| Q2 24 | — | 7.95× | ||
| Q1 24 | — | -2.58× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
